Estrella Immunopharma, Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
Business Address
5858 HORTON STREET, SUITE 370, EMERYVILLE, CA, 94608
Mailing Address
5858 HORTON STREET, SUITE 370, EMERYVILLE, CA, 94608
Phone
(510) 318-9098
Fiscal Year End
1231
EIN
861314502
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 18, 2026 | View on SEC |
| S-1/A IPO registration amendment | January 22, 2026 | View on SEC |
| S-1/A IPO registration amendment | January 16, 2026 | View on SEC |
| 8-K Current report of material events | January 13, 2026 | View on SEC |
| 424B5 Prospectus supplement | January 6, 2026 | View on SEC |
| 8-K Current report of material events | January 6, 2026 | View on SEC |
| S-1 IPO registration statement | December 22, 2025 | View on SEC |
| 8-K Current report of material events | December 4, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 12, 2025 | View on SEC |
| 8-K Current report of material events | November 6, 2025 | View on SEC |
Annual Reports
10-K
March 18, 2026
- Lead product candidate EB103 showed promising Phase I results with 100% complete response in high-dose group and no serious treatment-related side effects.
- The STARLIGHT-1 clinical trial for EB103 was approved to advance to Phase II by an independent Data Safety Monitoring Board (DSMB).
Material Events
8-K
Legal Issue
January 13, 2026
High Impact
- The company has 45 calendar days to submit a compliance plan to Nasdaq.
- Estrella Immunopharma plans to hold its annual shareholder meeting in April 2026.
Related Companies
Companies in the same industry (SIC: 2836)
Cardiff Oncology, Inc.
CRDF
Biological Products, (No Diagnostic Substances)
Immunovant, Inc.
IMVT
Biological Products, (No Diagnostic Substances)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
Kodiak Sciences Inc.
KOD
Biological Products, (No Diagnostic Substances)
Voyager Therapeutics, Inc.
VYGR
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.